NCT03648502

Brief Summary

There are currently no cognitive tests that have been validated as screening tools for people with dementia and comorbid hearing loss. This is particularly important given the high prevalence of hearing impairment in older adults presenting to memory services and the risk of misdiagnosis of dementia in this population as outlined above. Cognitive tests validated in hearing impaired populations will also be important as outcome tools for interventional research aiming to find out if treating hearing loss may reduce dementia risk in the longer term.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 2, 2018

Completed
25 days until next milestone

First Posted

Study publicly available on registry

August 27, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

November 9, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 13, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 13, 2020

Completed
Last Updated

November 9, 2020

Status Verified

November 1, 2020

Enrollment Period

1.3 years

First QC Date

August 2, 2018

Last Update Submit

November 5, 2020

Conditions

Keywords

dementiahearing lossauditory process

Outcome Measures

Primary Outcomes (2)

  • The adapted version Montreal Cognitive Assessment (MoCA) questionnaire total score among dementia/mild cognitive impairment/normal cognition group of hearing impaired older adult.

    The score will be used to calculate the appropriate cut-point score for differentiating each group of hearing impaired older adults.(total score ranging from 0-30 points with higher score indicate better cognitive function)

    approximately 1 years (expected to recruit 30 participants for each group)

  • The adapted version Addenbrooke's Cognitive Examination III (ACE-III) questionnaire total score among dementia/mild cognitive impairment/normal cognition group of hearing impaired older adult.

    The score will be used to calculate the appropriate cut-point score for differentiating each group of hearing impaired older adults (total score ranging from 0-100 points with higher score indicate better cognitive function)

    approximately 1 years (expected to recruit 30 participants for each group)

Secondary Outcomes (1)

  • Hearing handicap score from the Modified Amsterdam Inventory for Auditory Disability and Handicap (mAIAD) (total score ranging from 0-84 with higher score indicate smaller perceived hearing difficulty)

    approximately 1 years (expected to recruit 30 participants for each group)

Other Outcomes (1)

  • Final cognitive status diagnosis (base on ICD-10 coding system; dichotomous outcome; code F00-F03 (dementia) or code ICD F06.7 (Mild cognitive impairment)) provided by an NHS memory service doctors at routine clinical care follow up session at 1 year.

    1 year follow up from initial recruitment

Study Arms (3)

dementia (D-HI)

EXPERIMENTAL

hearing impaired dementia

Diagnostic Test: Cognitive tests and hearing tests

Mild cognitive impairment (MCI-HI)

OTHER

MCI with hearing loss

Diagnostic Test: Cognitive tests and hearing tests

normal (N-HI)

ACTIVE COMPARATOR

normal cognition with hearing loss

Diagnostic Test: Cognitive tests and hearing tests

Interventions

Several cognitive and hearing (peripheral and (central) auditory process) tests

Mild cognitive impairment (MCI-HI)dementia (D-HI)normal (N-HI)

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age over 65 years
  • Documented Hearing loss (currently wearing hearing aids and/or hearing testing with a hearing average of \>/= 30dB HL in D-HI,MCI-HI group)

You may not qualify if:

  • Uncorrected visual impairment; cognitive and/or physical disability(s) which prevent the performance of the written/drawing elements of the tests, in the opinion of the researcher.
  • Severe to profound hearing loss (PTA \>70dBHL)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Royal National Throat Nose Ear Hospital

London, WC1X 8DA, United Kingdom

Location

Camden and Islington NHS memory service

London, United Kingdom

Location

Related Publications (2)

  • MacDonald AA, Joyson A, Lee R, Seymour DG, Soiza RL. The effect of hearing augmentation on cognitive assessment scales at admission to hospital. Am J Geriatr Psychiatry. 2012 Apr;20(4):355-61. doi: 10.1097/JGP.0b013e3182107e88.

  • Lin FR, Yaffe K, Xia J, Xue QL, Harris TB, Purchase-Helzner E, Satterfield S, Ayonayon HN, Ferrucci L, Simonsick EM; Health ABC Study Group. Hearing loss and cognitive decline in older adults. JAMA Intern Med. 2013 Feb 25;173(4):293-9. doi: 10.1001/jamainternmed.2013.1868.

MeSH Terms

Conditions

DementiaHearing LossAuditory Perceptual Disorders

Interventions

Hearing Tests

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsAuditory Diseases, CentralRetrocochlear DiseasesPerceptual DisordersNeurobehavioral ManifestationsCognition Disorders

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, OtologicalDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Nattawan Utoomprurkporn, MD,Msc

    University College, London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: 3 participants arms Diagnostic tools validation
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 2, 2018

First Posted

August 27, 2018

Study Start

November 9, 2018

Primary Completion

March 13, 2020

Study Completion

March 13, 2020

Last Updated

November 9, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

only share within researchers team

Locations